Targeted muscle reinnervation: what the surgery is, who it's offered to, and what to expect

TMR is a nerve-transfer surgery with two main indications: reducing neuroma and phantom limb pain, and enabling more intuitive myoelectric prosthetic control. A patient-facing orientation to the procedure, candidacy, recovery, and what to ask your surgical team.

Targeted muscle reinnervation: what the surgery is, who it's offered to, and what to expect

At some point during rehabilitation — often when phantom pain or neuroma pain is proving hard to manage, or when a prosthetist brings up pattern recognition control — someone may mention targeted muscle reinnervation, usually by its initials. It is a surgical procedure, which means it belongs to a different conversation than socket fitting, but it affects what prosthetic options are available and what rehabilitation looks like. Understanding what it does and who it is typically offered to is useful before that conversation starts.

This is orientation information. It does not substitute for surgical consultation, and what applies to you specifically depends on your amputation level, anatomy, pain picture, and goals.


What TMR actually does

Targeted muscle reinnervation is a nerve-transfer surgery. When a limb is amputated, the motor and sensory nerve branches that used to serve it are severed. Those nerve ends do not simply stop — they try to grow, as nerves do. Without somewhere useful to go, they can form neuromas: tangled, sensitive masses of regenerating nerve fibers that are a common source of chronic pain in the residual limb.

TMR gives those nerve ends somewhere to go.

During the procedure, a surgeon identifies the severed nerve branches in the residual limb and connects each one to a small motor nerve branch serving a nearby muscle. The reinnervated muscles become the new targets for those nerve signals. Two things follow from this:

Pain reduction. Providing a pathway for nerve regeneration reduces the rate of symptomatic neuroma formation. There is also evidence that TMR reduces phantom limb pain — the exact mechanism is still being studied, but redirecting the nerve signals appears to dampen the disorganized signaling that contributes to phantom pain. Published outcomes data from the Walter Reed National Military Medical Center and the Shirley Ryan AbilityLab — two of the leading centers — show meaningful reductions in both residual limb and phantom pain in many patients following TMR.

Prosthetic control. When a reinnervated muscle contracts in response to the routed nerve signal, it produces a small electrical signal detectable by surface electrodes on the skin. For upper limb prosthetics users, this means additional, distinct control sites. Where a conventional myoelectric user might have two electrode sites (biceps and triceps), a person who has had TMR may have four or more — one for each of the nerve branches transferred. Each site corresponds to the movement the person intends to make with their missing limb. The result is a more intuitive control scheme, because the prosthetic system is reading signals that are functionally organized around intent.

These two benefits — pain and control — are related but distinct. TMR can be done primarily for pain reasons, primarily for prosthetic control reasons, or both.


The two main clinical contexts

Symptomatic neuromas and phantom limb pain

Neuromas develop in most amputations to some degree. Most are not severely symptomatic. When they are — when tapping or pressure on the residual limb causes sharp or radiating pain, or when phantom limb pain is persistent and severe — TMR is one of the surgical options now offered alongside older approaches like stump revision or neurectomy.

The evidence for TMR as a treatment for established neuroma pain is supported by multiple clinical series, including work published in the journal Plastic and Reconstructive Surgery and reviewed by the VA/DoD Limb Loss Task Force. It is not guaranteed to eliminate pain, and individual results vary. But for people with refractory neuroma or phantom pain who have not responded to conservative management, it is a reasonable option to discuss with a surgeon experienced in the procedure.

Lower limb amputees are candidates for TMR for pain, even though the prosthetic control benefit is less often the primary motivation. The surgical sites and nerve anatomy are different, but the principle — redirect the nerve to reduce neuroma formation — applies.

Improving upper limb prosthetic control

For people with transradial (below-elbow), transhumeral (above-elbow), or higher-level upper limb amputations, TMR can substantially expand what a myoelectric prosthesis can do.

Standard myoelectric prosthetics rely on the remaining muscles in the residual limb — typically the flexors and extensors that survive the amputation. For transradial users, those muscles are usually enough to operate a hand opener and closer with reasonable reliability. For transhumeral users, the available signals are fewer, and more complex function — rotating the wrist while also controlling the elbow, for instance — requires either sequential control (switching between functions manually) or sophisticated signal processing.

TMR provides additional signal sites. When those signals are processed through a pattern recognition system rather than conventional threshold-based control, the user can perform different grip patterns and multi-joint movements by simply intending them — the system learns to recognize the pattern of muscle activity associated with each intended motion. This is meaningfully different from the conventional approach, which requires deliberate, isolated muscle contractions.

Not every transradial user needs TMR — conventional myoelectric control works well for many people. It becomes most relevant when someone wants access to more complex function, has found that conventional control is too effortful or unreliable, or has significant neuroma or phantom pain alongside their prosthetic goals.


Timing: proactive versus after the fact

TMR can be performed in two contexts.

Proactive TMR is performed at the time of amputation, during the same surgical session or in a planned early revision. This approach has grown in use as evidence has accumulated that proactive TMR significantly reduces the rate of symptomatic neuroma formation compared with leaving nerve ends untreated. It also preserves nerve length, which matters because nerves need to reach the target muscle. Surgeons planning proactive TMR identify nerve branches during the amputation and connect them to nearby motor branches before closure.

Not every amputation is planned in advance, and not every surgical setting has a surgeon trained in TMR available at the time of limb loss. Traumatic and emergency amputations frequently proceed without it. Proactive TMR is most reliably available at major academic centers, military medical centers, and VA facilities with established limb loss programs.

TMR after the fact — for established pain or to expand prosthetic options — is performed as a planned procedure, usually as a day surgery or short-stay procedure under general anesthesia. The surgeon identifies and dissects the nerve branches in the residual limb, which can be more involved in a mature residual limb than in one operated on recently, but is well-described in the surgical literature.

There is no hard rule about when TMR is too late. People have undergone the procedure years after amputation, primarily for pain. For prosthetic control, later surgery is also possible, though the nerve-muscle reinnervation still needs time to establish after any TMR procedure.


What the surgery involves

The procedure is performed by a plastic and reconstructive surgeon or an orthopedic surgeon with specific training in peripheral nerve work. General anesthesia is standard. Operating time varies by the number of transfers performed and the anatomy — a straightforward transradial TMR with two or three transfers might take two hours; a transhumeral procedure with four transfers takes longer.

Surgeons identify the major nerve branches in the residual limb using surgical anatomy and, in some cases, intraoperative nerve stimulation. The target muscles — small muscles that have accessible motor nerve branches and are in proximity to the transferred nerve — are selected based on anatomy and the control signals being created. Each severed nerve is sutured to the motor branch of a target muscle.

The procedure leaves the residual limb structurally the same. Socket fit after healing is typically unaffected, though there is a recovery period.


Recovery and reinnervation timeline

The surgical incision heals over two to four weeks, similar to other residual limb procedures. After that, the key process is reinnervation: the transferred nerve growing into the target muscle and establishing functional connections. Nerves grow approximately one millimeter per day under good conditions. Depending on the distance from the nerve suture to the target muscle — often a few centimeters — meaningful reinnervation typically begins at three to six months post-surgery.

During this period, the muscle is silent from a myoelectric standpoint. There is nothing to fit yet, and the prosthesis use pattern may not change immediately. Some people continue wearing their existing prosthesis during recovery if the residual limb tolerates it; others take a break during healing.

Once reinnervation progresses, the target muscles begin to produce detectable signals. At that point, fitting work begins: the prosthetist maps electrode positions to the reinnervated sites, and the user starts learning to activate them intentionally. This is where the rehabilitation investment is concentrated — learning to produce clean, isolated signals for each muscle site, then learning to coordinate them for prosthetic function.

For pattern recognition control systems, a training phase follows: the user performs a set of intended movements while the system records the associated signal patterns, building a classifier that translates those patterns into prosthetic commands. This training requires multiple sessions and improves with practice.

Full functional integration — where the control feels reliable and low-effort rather than deliberate — typically takes six to twelve months from surgery, with ongoing improvement beyond that.


Where TMR is available

TMR is not available at every hospital or prosthetist’s office. The procedure requires a surgeon trained specifically in peripheral nerve transfer and TMR methodology. Major centers with established programs include the Shirley Ryan AbilityLab in Chicago (where the technique was developed by Todd Kuiken, MD, PhD, and Gregory Dumanian, MD, in the early 2000s), Walter Reed National Military Medical Center in Bethesda, and a number of VA medical centers that have prioritized limb loss care. Several academic medical centers with high-volume orthopedic and plastic surgery programs have also trained surgeons in the technique.

Access has expanded significantly since the early 2010s, partly due to VA investment and military research funding, partly due to the technique’s uptake in the civilian surgical community. It is no longer confined to a handful of centers, but the distribution is uneven. Someone in a major metropolitan area near an academic medical center is more likely to have access than someone in a rural area with limited surgical options.

Identifying a TMR-trained surgeon typically requires starting with a physiatrist or rehabilitation physician who is familiar with the technique and can make a referral. Major amputee rehabilitation programs — not just prosthetics clinics — are the most direct route.


Coverage and cost

The surgical procedure itself — nerve transfer surgery — is generally covered by insurance under existing peripheral nerve repair codes. TMR is not a new experimental approach for insurance purposes; it has been performed for over twenty years and has enough published outcomes data to be recognized as an established technique.

VA coverage for veterans is more straightforward at facilities with TMR programs; veterans who received their amputation care through VA and have ongoing care there should ask their prosthetics or surgical team whether TMR is available and indicated.

The more complicated coverage issue is often the post-surgical prosthetic fitting. Pattern recognition control systems require additional electrode coverage and dedicated software. Not all insurers cover pattern recognition systems under standard prosthetic benefits. This is worth discussing with a prosthetist and understanding before surgery if expanded prosthetic control is a primary motivation — the surgery itself may be covered, but what happens on the prosthetics side depends on your specific plan.


Questions to bring to a surgical consultation

If a surgeon, prosthetist, or rehabilitation physician is suggesting TMR as an option, some questions that may help clarify whether it fits your situation:

  • Is the primary goal pain reduction, improved prosthetic control, or both? What does the evidence say for my specific situation?
  • How many TMR procedures has this surgical team performed?
  • Are there intraoperative nerve stimulation tools in use, or does the surgeon work from anatomy alone?
  • How many nerve transfers would be planned, and where are the target muscles?
  • What does the reinnervation timeline look like for my anatomy and amputation level?
  • What prosthetic system and electrode configuration would be used after reinnervation, and is that system covered under my benefits?
  • What is the plan if the reinnervated signals are not clean or are difficult to discriminate?
  • Is there a patient who has gone through the same procedure at this center I could speak with?

Amputee News does not provide individualized medical or surgical advice. Whether TMR is appropriate, and what form it should take, depends on individual anatomy, pain history, prosthetic goals, and clinical assessment. This guide is general orientation for people who want to understand the procedure before or during a clinical conversation. Published outcomes cited here reflect the peer-reviewed and clinical literature available at time of writing; clinical practices and coverage policies change, and your care team is the authoritative source for current guidance.